Donna L. Tempel
Chief Executive Officer at Seldar Pharma, Inc.
Profile
Dr. Donna L.
Tempel is a President & Chief Executive Officer at Seldar Pharma, Inc. Dr. Tempel was previously employed as a President & Chief Executive Officer by Drais Pharmaceuticals Inc., a Chief Operating Officer & Head-Investor Relations by AkaRx, Inc., a Secretary by BioNJ, Inc., a Principal by Bristol Myers Squibb Co., a Principal by Johnson & Johnson, and a Chief Operating Officer by Yamanouchi Pharma America, Inc. She received her undergraduate degree from Hunter College, an MBA from Fairleigh Dickinson University and a doctorate degree from John Jay College of Criminal Justice.
Donna L. Tempel active positions
| Companies | Position | Start |
|---|---|---|
Seldar Pharma, Inc.
 Seldar Pharma, Inc. Pharmaceuticals: MajorHealth Technology Seldar Pharma, Inc. develops and commercializes astellas for irritable bowel syndrome with diarrhea. The company is headquartered in Bridgewater, NJ. | Chief Executive Officer | - |
Former positions of Donna L. Tempel
| Companies | Position | End |
|---|---|---|
Drais Pharmaceuticals Inc.
 Drais Pharmaceuticals Inc. Pharmaceuticals: MajorHealth Technology Drais Pharmaceuticals, Inc. manufactures pharmaceutical and provides therapeutic treatments. The company was founded by Donna L. Tempel and Robert E. Desjardins in 2007 and is headquartered in Bridgewater, NJ. | Chief Executive Officer | 30/11/2023 |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Director/Board Member | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
| Yamanouchi Pharma America, Inc. | Chief Operating Officer | - |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
Training of Donna L. Tempel
| Hunter College | Undergraduate Degree |
| Fairleigh Dickinson University | Masters Business Admin |
| John Jay College of Criminal Justice | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| Private companies | 5 |
|---|---|
AkaRx, Inc.
 AkaRx, Inc. Pharmaceuticals: MajorHealth Technology AkaRx, Inc. engages in the develop and manufacture of biopharmaceutical products for applications in hematology and therapeutic treatments for clinical-stage cancer. It offers thrombocytopenia treatment avatrombopag. The company was founded by Robert E. Desjardins and Donna Tempel in 2005 and is headquartered in NJ. | Health Technology |
Drais Pharmaceuticals Inc.
Drais Pharmaceuticals Inc. Pharmaceuticals: MajorHealth Technology Drais Pharmaceuticals, Inc. manufactures pharmaceutical and provides therapeutic treatments. The company was founded by Donna L. Tempel and Robert E. Desjardins in 2007 and is headquartered in Bridgewater, NJ. | Health Technology |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Commercial Services |
| Yamanouchi Pharma America, Inc. | |
Seldar Pharma, Inc.
Seldar Pharma, Inc. Pharmaceuticals: MajorHealth Technology Seldar Pharma, Inc. develops and commercializes astellas for irritable bowel syndrome with diarrhea. The company is headquartered in Bridgewater, NJ. | Health Technology |
- Stock Market
- Insiders
- Donna L. Tempel